Literature DB >> 26693269

Antidotes for patients taking novel oral anti-coagulants.

Stefanie W Yip1, Yiu Che Chan1.   

Abstract

Entities:  

Year:  2015        PMID： 26693269      PMCID： PMC4677077          DOI： 10.5847/wjem.j.1920-8642.2015.04.012

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN： 1920-8642


× No keyword cloud information.
  7 in total

Review 1.  Reversal of anticoagulants: an overview of current developments.

Authors:  Andreas Greinacher; Thomas Thiele; Kathleen Selleng
Journal:  Thromb Haemost       Date:  2015-04-02       Impact factor: 5.249

Review 2.  Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.

Authors:  Andres Enriquez; Gregory Y H Lip; Adrian Baranchuk
Journal:  Europace       Date:  2015-03-26       Impact factor: 5.214

3.  EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2013-04-26       Impact factor: 29.983

4.  Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.

Authors:  Jasper Dinkelaar; Sanne Patiwael; Job Harenberg; Anja Leyte; Herm Jan M Brinkman
Journal:  Clin Chem Lab Med       Date:  2014-11       Impact factor: 3.694

5.  Perioperative management of patients on new oral anticoagulants.

Authors:  A Lai; N Davidson; S W Galloway; J Thachil
Journal:  Br J Surg       Date:  2014-04-29       Impact factor: 6.939

Review 6.  Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.

Authors:  Karsten M H Bruins Slot; Eivind Berge
Journal:  Cochrane Database Syst Rev       Date:  2013-08-08

7.  Use of PER977 to reverse the anticoagulant effect of edoxaban.

Authors:  Jack E Ansell; Sasha H Bakhru; Bryan E Laulicht; Solomon S Steiner; Michael Grosso; Karen Brown; Victor Dishy; Robert J Noveck; James C Costin
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.